Freshpet (FRPT) 10-Q 3 Nov 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Oct. 30, 2020
Document Information [Line Items]
Entity Central Index Key	0001611647
Entity Registrant Name	Freshpet INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-36729
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-1884894
Entity Address, Address Line One	400 Plaza Drive, 1st Floor
Entity Address, City or Town	Secaucus
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07094
City Area Code	201
Local Phone Number	520-4000
Title of 12(b) Security	Common Stock
Trading Symbol	FRPT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		40,640,010

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)		Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents		$ 84,184,714	$ 9,471,676
Short-term investments		10,000,000	0
Accounts receivable, net of allowance for doubtful accounts		21,644,451	18,580,840
Inventories, net		17,510,839	12,542,269
Prepaid expenses		3,411,293	3,275,992
Other current assets(1)	[1]	730,596	10,452,990
Total Current Assets		137,481,893	54,323,767
Property, plant and equipment, net		242,299,147	165,287,597
Deposits on equipment		5,669,151	3,600,931
Operating lease right of use assets		8,192,272	9,154,234
Equity method investment		27,749,501	0
Other assets		4,550,532	3,759,058
Total Assets		425,942,496	236,125,587
CURRENT LIABILITIES:
Accounts payable		10,742,536	18,667,729
Accrued expenses(1)	[1]	11,958,320	22,132,928
Current operating lease liabilities		1,269,380	1,185,058
Total Current Liabilities		23,970,236	41,985,715
Long term debt		0	54,466,099
Long term operating lease liabilities		7,483,060	8,409,252
Total Liabilities		31,453,296	104,861,066
STOCKHOLDERS' EQUITY:
Common stock — voting, $0.001 par value, 200,000,000 shares authorized, 40,645,047 issued and 40,630,878 outstanding on September 30, 2020, and 36,162,433 issued and 36,148,264 outstanding on December 31, 2019		40,645	36,162
Additional paid-in capital		597,368,593	334,299,172
Accumulated deficit		(202,625,523)	(202,735,417)
Accumulated other comprehensive income (loss)		(38,289)	(79,170)
Treasury stock, at cost — 14,169 shares on September 30, 2020 and on December 31, 2019		(256,226)	(256,226)
Total Stockholders' Equity		394,489,200	131,264,521
Total Liabilities and Stockholders' Equity		$ 425,942,496	$ 236,125,587
[1]	See Note 11 for additional information.

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	200,000,000	200,000,000
Common stock, issued (in shares)	40,645,047	36,162,433
Common stock, outstanding (in shares)	40,630,878	36,148,264
Treasury stock, shares (in shares)	14,169	14,169

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
NET SALES	$ 84,189,912	$ 65,265,901	$ 234,267,776	$ 180,110,282
COST OF GOODS SOLD	47,535,488	34,560,261	131,890,646	96,163,080
GROSS PROFIT	36,654,424	30,705,640	102,377,130	83,947,202
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES	32,894,793	27,171,138	101,272,838	89,075,672
INCOME (LOSS) FROM OPERATIONS	3,759,631	3,534,502	1,104,292	(5,128,470)
OTHER INCOME/(EXPENSES):
Other Income/(Expenses), net	24,663	(137,624)	69,766	(141,077)
Interest Expense	(215,661)	(310,465)	(999,364)	(688,890)
Nonoperating Income (Expense), Total	(190,998)	(448,089)	(929,598)	(829,967)
INCOME (LOSS) BEFORE INCOME TAXES	3,568,633	3,086,413	174,694	(5,958,437)
INCOME TAX EXPENSE	21,600	19,250	64,800	57,750
INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	3,547,033	3,067,163	109,894	(6,016,187)
OTHER COMPREHENSIVE INCOME (LOSS):
Change in foreign currency translation	368,492	(81,667)	40,881	(143,941)
TOTAL OTHER COMPREHENSIVE INCOME (LOSS)	368,492	(81,667)	40,881	(143,941)
TOTAL COMPREHENSIVE INCOME (LOSS)	$ 3,915,525	$ 2,985,496	$ 150,775	$ (6,160,128)
NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC (in dollars per share)	$ 0.09	$ 0.09	$ 0	$ (0.17)
-DILUTED (in dollars per share)	$ 0.09	$ 0.08	$ 0	$ (0.17)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING USED IN COMPUTING NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC (in shares)	40,560,104	36,079,935	39,451,675	35,894,377
-DILUTED (in shares)	41,699,862	37,289,478	40,473,290	35,894,377

Changes to Statements of Stockh

Changes to Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Total
BALANCES (in shares) at Dec. 31, 2018	35,556,595				14,169
BALANCES at Dec. 31, 2018	$ 35,556	$ 323,079,437	$ (201,352,682)	$ (31,610)	$ (256,226)	$ 121,474,475
Exercise of options to purchase common stock (in shares)	248,195				0
Exercise of options to purchase common stock	$ 248	1,791,420	0	0	$ 0	1,791,668
Issuance of restricted stock units (in shares)	61,532				0
Issuance of restricted stock units	$ 62	(673,836)	0	0	$ 0	(673,774)
Share-based compensation expense	0	1,260,126	0	0	0	1,260,126
Foreign Currency Translation	0	0	0	91,047	0	91,047
Net income (loss)	$ 0	0	(3,422,000)	0	$ 0	(3,422,000)
BALANCES (in shares) at Mar. 31, 2019	35,866,322				14,169
BALANCES at Mar. 31, 2019	$ 35,866	325,457,147	(204,774,682)	59,437	$ (256,226)	120,521,542
BALANCES (in shares) at Dec. 31, 2018	35,556,595				14,169
BALANCES at Dec. 31, 2018	$ 35,556	323,079,437	(201,352,682)	(31,610)	$ (256,226)	121,474,475
Foreign Currency Translation						(143,941)
Net income (loss)						(6,016,187)
BALANCES (in shares) at Sep. 30, 2019	36,100,662				14,169
BALANCES at Sep. 30, 2019	$ 36,100	331,538,514	(207,368,869)	(175,551)	$ (256,226)	123,773,968
BALANCES (in shares) at Mar. 31, 2019	35,866,322				14,169
BALANCES at Mar. 31, 2019	$ 35,866	325,457,147	(204,774,682)	59,437	$ (256,226)	120,521,542
Exercise of options to purchase common stock (in shares)	194,497				0
Exercise of options to purchase common stock	$ 194	1,983,685	0	0	$ 0	1,983,879
Issuance of restricted stock units (in shares)	29,126				0
Issuance of restricted stock units	$ 29	(579,207)	0	0	$ 0	(579,178)
Share-based compensation expense	0	1,480,882	0	0	0	1,480,882
Foreign Currency Translation	0	0	0	(153,321)	0	(153,321)
Net income (loss)	$ 0	0	(5,661,350)	0	$ 0	(5,661,350)
BALANCES (in shares) at Jun. 30, 2019	36,089,945				14,169
BALANCES at Jun. 30, 2019	$ 36,089	328,342,507	(210,436,032)	(93,884)	$ (256,226)	117,592,454
Exercise of options to purchase common stock (in shares)	10,717				0
Exercise of options to purchase common stock	$ 11	66,359	0	0	$ 0	66,370
Share-based compensation expense	0	3,129,648	0	0	0	3,129,648
Foreign Currency Translation	0	0	0	(81,667)	0	(81,667)
Net income (loss)	$ 0	0	3,067,163	0	$ 0	3,067,163
BALANCES (in shares) at Sep. 30, 2019	36,100,662				14,169
BALANCES at Sep. 30, 2019	$ 36,100	331,538,514	(207,368,869)	(175,551)	$ (256,226)	123,773,968
BALANCES (in shares) at Dec. 31, 2019	36,162,433				14,169
BALANCES at Dec. 31, 2019	$ 36,162	334,299,172	(202,735,417)	(79,170)	$ (256,226)	131,264,521
Exercise of options to purchase common stock (in shares)	44,156				0
Exercise of options to purchase common stock	$ 44	402,512	0	0	$ 0	402,556
Issuance of restricted stock units (in shares)	64,823				0
Issuance of restricted stock units	$ 65	(644,664)	0	0	$ 0	(644,599)
Share-based compensation expense	$ 0	2,241,847	0	0	$ 0	2,241,847
Shares issued in primary offering (in shares)	3,999,999				0
Shares issued in primary offering	$ 4,000	252,058,254	0	0	$ 0	252,062,254
Foreign Currency Translation	0	0	0	58,955	0	58,955
Net income (loss)	$ 0	0	(3,590,233)	0	$ 0	(3,590,233)
BALANCES (in shares) at Mar. 31, 2020	40,271,411				14,169
BALANCES at Mar. 31, 2020	$ 40,271	588,357,121	(206,325,650)	(20,215)	$ (256,226)	381,795,301
BALANCES (in shares) at Dec. 31, 2019	36,162,433				14,169
BALANCES at Dec. 31, 2019	$ 36,162	334,299,172	(202,735,417)	(79,170)	$ (256,226)	131,264,521
Foreign Currency Translation						40,881
Net income (loss)						109,894
BALANCES (in shares) at Sep. 30, 2020	40,645,047				14,169
BALANCES at Sep. 30, 2020	$ 40,645	597,368,593	(202,625,523)	(38,289)	$ (256,226)	394,489,200
BALANCES (in shares) at Mar. 31, 2020	40,271,411				14,169
BALANCES at Mar. 31, 2020	$ 40,271	588,357,121	(206,325,650)	(20,215)	$ (256,226)	381,795,301
Exercise of options to purchase common stock (in shares)	199,796				0
Exercise of options to purchase common stock	$ 200	1,687,780	0	0	$ 0	1,687,980
Issuance of restricted stock units (in shares)	9,018				0
Issuance of restricted stock units	$ 9	(991,706)	0	0	$ 0	(991,697)
Share-based compensation expense	0	2,332,915	0	0	0	2,332,915
Foreign Currency Translation	0	0	0	(386,566)	0	(386,566)
Net income (loss)	$ 0	0	153,094	0	$ 0	153,094
BALANCES (in shares) at Jun. 30, 2020	40,480,225				14,169
BALANCES at Jun. 30, 2020	$ 40,480	591,386,109	(206,172,556)	(406,781)	$ (256,226)	384,591,026
Exercise of options to purchase common stock (in shares)	164,089				0
Exercise of options to purchase common stock	$ 164	2,572,756	0	0	$ 0	2,572,920
Issuance of restricted stock units (in shares)	733				0
Issuance of restricted stock units	$ 1	0	0	0	$ 0	1
Share-based compensation expense	0	3,409,728	0	0	0	3,409,728
Foreign Currency Translation	0	0	0	368,492	0	368,492
Net income (loss)	$ 0	0	3,547,033	0	$ 0	3,547,033
BALANCES (in shares) at Sep. 30, 2020	40,645,047				14,169
BALANCES at Sep. 30, 2020	$ 40,645	$ 597,368,593	$ (202,625,523)	$ (38,289)	$ (256,226)	$ 394,489,200

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 3,547,033	$ (3,590,233)	$ 3,067,163	$ (3,422,000)	$ 109,894	$ (6,016,187)
Adjustments to reconcile net income (loss) to net cash flows provided by operating activities:
Provision for loss/(gains) on accounts receivable					(3,826)	104,700
Loss on disposal of equipment					1,300,519	138,106
Share-based compensation					7,811,081	5,706,580
Inventory obsolescence					146,830	104,624
Depreciation and amortization					14,945,758	11,707,422
Amortization of deferred financing costs and loan discount					762,555	125,303
Changes in operating assets and liabilities:
Accounts receivable					(3,059,785)	(7,278,751)
Inventories					(5,115,400)	(4,094,386)
Prepaid expenses and other current assets					9,587,093	(10,650,214)
Operating lease right of use					961,962	125,711
Other assets					(221,614)	(608,060)
Accounts payable					(3,021,045)	3,742,265
Accrued expenses					(10,299,608)	10,396,504
Other lease liabilities					(841,870)	(17,018)
Net cash flows from operating activities					13,062,544	3,486,599
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term investments					(20,001,196)	0
Proceeds from maturities of short-term investments					10,001,196	0
Investments in equity method investment					(27,624,501)	0
Acquisitions of property, plant and equipment, software and deposits on equipment					(99,923,887)	(40,738,346)
Net cash flows used in investing activities					(137,548,388)	(40,738,346)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from common shares issued in primary offering, net of issuance cost					252,062,254	0
Proceeds from exercise of options to purchase common stock					4,663,456	3,841,918
Tax withholdings related to net shares settlements of restricted stock units					(1,636,296)	(1,252,953)
Proceeds from borrowings under Credit Facilities					20,933,000	50,620,988
Repayment of borrowings under Credit Facilities					(76,000,000)	(15,900,000)
Financing fees paid in connection with borrowings					(823,532)	(406,859)
Net cash flows provided by financing activities					199,198,882	36,903,094
NET CHANGE IN CASH AND CASH EQUIVALENTS					74,713,038	(348,653)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR		$ 9,471,676		$ 7,554,388	9,471,676	7,554,388	$ 7,554,388
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 84,184,714		$ 7,205,735		84,184,714	7,205,735	$ 9,471,676
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid					925,396	521,688
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Property, plant and equipment purchases in accounts payable					$ 2,670,367	$ 5,781,915

Note 1 - Nature of the Business

Note 1 - Nature of the Business and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Business Description and Accounting Policies [Text Block]	Note 1 Nature of the Business Basis of Presentation September 30, 2020 three nine September 30, 2020 2019 nine September 30, 2020 2019 three nine September 30, 2020 not December 31, 2020 may not These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 10 December 31, 2019 Equity method investment not 20% may one In applying the equity method, the Company records the investment at cost and subsequently increases or decreases the carrying amount of the investment by our proportionate share of the net income or loss. Variable interest entities ("VIEs") Estimates and Uncertainties Fair Value of Financial Instruments 1 3 The three • Level 1 1 • Level 2 1 not 2 • Level 3 3 one The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments. Certain assets, including the equity method investment, right-of-use assets and property and equipment are also subject to measurement at fair value on a non-recurring basis if they are deemed to be impaired as a result of an impairment review. As of September 30, 2020 2 1 Short-Term Investments three one Trade accounts receivable may Restricted Stock Tax Withholdings nine September 30, 2020, nine September 30, 2019. three September 30, 2020 2019. not Debt Issuance Cost first 2020, During the second 2020, September 30, 2020 The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan. Net Sales Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Grocery (including Online), Mass and Club $ 71,025,035 $ 54,712,007 $ 200,128,333 $ 150,340,440 Pet Specialty and Natural 13,164,877 10,553,894 34,139,443 29,769,842 Net Sales $ 84,189,912 $ 65,265,901 $ 234,267,776 $ 180,110,282 Recently Issued Accounting Standards In June 2016, No. 2016 13, Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments. December 15, 2019, three nine September 30, 2020 2016 13. not In January 2020, No. 2020 01, 321 323 815 321, 323, 815. December 15, 2020, not

Note 2 - Inventories

Note 2 - Inventories	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Inventory Disclosure [Text Block]	Note 2 September 30, December 31, 2020 2019 Raw Materials and Work in Process $ 6,894,283 $ 4,453,498 Packaging Components Material 1,502,385 1,419,155 Finished Goods 9,589,548 6,842,359 17,986,216 12,715,012 Reserve for Obsolete Inventory (475,377 ) (172,743 ) $ 17,510,839 $ 12,542,269

Note 3 - Property, Plant and Eq

Note 3 - Property, Plant and Equipment	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 3 September 30, December 31, 2020 2019 Refrigeration Equipment $ 104,739,451 $ 97,568,137 Machinery and Equipment 70,312,048 54,274,118 Building, Land, and Improvements 27,388,013 25,621,495 Furniture and Office Equipment 5,091,775 4,931,703 Leasehold Improvements 740,385 395,241 Automotive Equipment 159,819 309,137 Construction in Progress 116,949,086 58,587,375 325,380,577 241,687,206 Less: Accumulated Depreciation (83,081,430 ) (76,399,609 ) $ 242,299,147 $ 165,287,597 Depreciation expense related to property, plant and equipment totaled $4,970,451 and $14,708,962 for the three nine September 30, 2020 three nine September 30, 2020 Depreciation expense related to property, plant and equipment totaled $3,975,822 and $11,462,514 for the three nine September 30, 2019 three nine September 30, 2019

Note 4 - Equity Method Investme

Note 4 - Equity Method Investment	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Equity Method Investments and Joint Ventures Disclosure [Text Block]	Note 4 On September 2, 2020, $27.7 not not 20%. There is no equity in income (loss) of equity method investment included in our Consolidated Statement of Operations and Comprehensive Loss (Unaudited) for the periods presented because the Company has elected to record their equity in income (loss) using a one fourth 2020,

Note 5 - Accrued Expenses

Note 5 - Accrued Expenses	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	Note 5 September 30, December 31, 2020 2019 Legal Contingency (1) - 10,100,000 Accrued Compensation and Employee Related Costs 5,302,127 6,390,692 Accrued Chiller Cost 2,129,179 1,576,214 Accrued Customer Consideration 972,344 635,399 Accrued Freight 1,072,878 702,673 Accrued Production Expenses 839,193 413,550 Accrued Marketing 531,966 1,187,885 Other Accrued Expenses 1,110,633 1,126,515 $ 11,958,320 $ 22,132,928 ( 1 See Note 11

Note 6 - Debt

Note 6 - Debt	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 6 On April 17, 2020, May 15, 2019. The New Credit Facility matures on April 17, 2025 no October 17, 2022, December 31, 2022, 1/28th April 17, 2025. Borrowings under the New Credit Facility are secured by substantially all of the Company's and certain of its subsidiaries' assets. The New Loan Agreement requires compliance with various covenants customary for agreements of this type, including financial covenants and negative covenants that limit, among other things, the Company's ability to incur additional debt, create or incur liens, engage in mergers or consolidations, sell, transfer or otherwise dispose of assets, make voluntary prepayments to subordinated debt, permit a change of control, pay dividends or distributions, make investments, and enter into certain transactions with affiliates. The New Loan Agreement also includes events of default customary for agreements of this type. During the nine September 30, 2020 $76.0 September 30, 2020 Net borrowings under the Credit Facilities totaled $54.5 million at December 31, 2019 In connection with entering into the New Credit Facility, the Company incurred $0.8 million of debt issuance cost which is capitalized on the balance sheet and amortized over the life of the New Credit Facility. As of September 30, 2020

Note 7 - Leases

Note 7 - Leases	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	Note 7– We have various noncancelable lease agreements for office and warehouse space, as well as office equipment, with original remaining lease terms of two nine five not not not Weighted-average remaining lease term (in years) and discount rate related to operating leases were as follows: Weighted-average remaining lease term 5.53 Weighted-average discount rate 6.14 % As most of our leases do not Maturities of lease liabilities under noncancelable operating leases as of September 30, 2020 September 30, 2020 2020 (a) 432,786 2021 1,760,250 2022 1,767,797 2023 1,802,007 2024 1,511,214 2025 and beyond 2,786,004 Total lease payments 10,060,058 Less: Imputed interest (1,358,752 ) Present value of lease liabilities $ 8,701,306 (a) Excluding the nine September 30, 2020 A summary of rent expense for the three nine September 30, 2020 2019 For the Three Months Ended For the Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Operating lease cost $ 446,598 $ 452,155 $ 1,349,055 $ 1,153,370 Supplemental cash flow information and non-cash activity relating to operating leases are as follows: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Operating cash flow information: Cash paid for amounts included in the measurement of lease liabilities $ 432,786 $ 395,408 $ 1,273,994 $ 1,022,188

Note 8 - Equity Incentive Plans

Note 8 - Equity Incentive Plans	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	Note 8 Total compensation cost for share-based payments recognized for the three September 30, 2020 2019 nine September 30, 2020 2019 2010 two four September 30, 2020 2010 2010 2014 November 2014, 2014 “2014 September 2020, 2014 may September 30, 2020 three one 2014 At September 30, 2020 2014 NASDAQ Marketplace Rules Inducement Award 2016 nine September 30, 2020 2014 four three Service Period Stock Options The following table includes activity related to outstanding service period stock options during the nine September 30, 2020 Service Period Stock Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,359,990 $ 11.50 Granted 59,782 65.62 Exercised (361,446 ) 8.86 Forfeited (357 ) 11.00 Outstanding at September 30, 2020 1,057,969 $ 15.46 Performance-Vested Stock Options The following table includes activity related to outstanding performance-vested stock options during the nine September 30, 2020 Performance Based Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,372,819 $ 18.31 Granted 19,317 63.87 Exercised (46,595 ) 31.54 Outstanding at September 30, 2020 1,345,541 $ 18.51 As of September 30, 2020 nine September 30, 2020 Restricted Stock Units The following table includes activity related to outstanding restricted stock units during the nine September 30, 2020 Restricted Stock Units Shares Weighted-Average Grant-Date Fair Value Per Unit Outstanding at December 31, 2019 240,229 $ 29.07 Granted 55,163 64.58 Issued upon vesting (100,587 ) 30.74 Forfeited (1,102 ) 41.88 Outstanding at September 30, 2020 193,703 $ 38.24

Note 9 - Earnings Per Share Att

Note 9 - Earnings Per Share Attributable to Common Shareholder	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 9 Basic net earnings (loss) per share of common stock is calculated by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net earnings (loss) per share of common stock is computed by giving effect to all potentially dilutive securities. The following table includes adjustments between weighted average common shares outstanding, for basic earnings per share and weighted average common shares outstanding for diluted earnings per share. For the three nine September 30, 2020 2019, no Three months ended Nine Months Ended September 30, September 30, 2020 2019 2020 Net Income (Loss) Attributable to Common Stockholders $ 3,547,033 $ 3,067,163 $ 109,894 Weighted Average Common Shares Outstanding, Basic 40,560,104 36,079,935 39,451,675 Dilutive Effect of Share-Based Awards: Service Period Stock Options 977,604 1,037,873 880,177 Restricted Stock Units 141,020 152,661 121,263 Performance 21,135 19,009 20,175 Weighted Average Common Shares Outstanding, Diluted 41,699,862 37,289,478 40,473,290 Basic Earnings per Share $ 0.09 $ 0.09 $ 0.00 Diluted Earnings per Share $ 0.09 $ 0.08 $ 0.00 The potentially dilutive securities are as follows: Nine Months Ended September 30, 2019 Service Period Stock Options 1,535,762 Restricted Stock Units 234,091 Performance Stock Options 24,246 Total 1,794,099 For the nine September 30, 2019, Performance awards are excluded from the calculation of dilutive potential common shares until the threshold performance conditions have been satisfied.

Note 10 - Concentrations

Note 10 - Concentrations	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	Note 10 Concentration of Credit Risk may

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 11 A shareholder derivative lawsuit, Meldon v. Freshpet, Inc. et al, Docket No. 2:18 10166, June 5, 2018 June 2018. April 3, 2019, August 4, 2020. September 30, 2020 In addition, we are currently involved in various claims and legal actions that arise in the ordinary course of our business, including claims resulting from employment related matters. None

Note 12 - Subsequent Events

Note 12 - Subsequent Events	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	Note 12 The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued for recognitions or disclosures. The Company did not

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Nature of the Business [Policy Text Block]	Nature of the Business
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation September 30, 2020 three nine September 30, 2020 2019 nine September 30, 2020 2019 three nine September 30, 2020 not December 31, 2020 may not These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 10 December 31, 2019
Equity Method Investments [Policy Text Block]	Equity method investment not 20% may one In applying the equity method, the Company records the investment at cost and subsequently increases or decreases the carrying amount of the investment by our proportionate share of the net income or loss.
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	Variable interest entities ("VIEs")
Use of Estimates, Policy [Policy Text Block]	Estimates and Uncertainties
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments 1 3 The three • Level 1 1 • Level 2 1 not 2 • Level 3 3 one The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments. Certain assets, including the equity method investment, right-of-use assets and property and equipment are also subject to measurement at fair value on a non-recurring basis if they are deemed to be impaired as a result of an impairment review. As of September 30, 2020 2 1
Marketable Securities, Policy [Policy Text Block]	Short-Term Investments three one
Receivable [Policy Text Block]	Trade accounts receivable may
Restricted Stock Tax Withholdings [Policy Text Block]	Restricted Stock Tax Withholdings nine September 30, 2020, nine September 30, 2019. three September 30, 2020 2019. not
Debt Issuance Cost [Policy Text Block]	Debt Issuance Cost first 2020, During the second 2020, September 30, 2020 The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan.
Revenue from Contract with Customer [Policy Text Block]	Net Sales Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Grocery (including Online), Mass and Club $ 71,025,035 $ 54,712,007 $ 200,128,333 $ 150,340,440 Pet Specialty and Natural 13,164,877 10,553,894 34,139,443 29,769,842 Net Sales $ 84,189,912 $ 65,265,901 $ 234,267,776 $ 180,110,282
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards In June 2016, No. 2016 13, Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments. December 15, 2019, three nine September 30, 2020 2016 13. not In January 2020, No. 2020 01, 321 323 815 321, 323, 815. December 15, 2020, not

Note 1 - Nature of the Busine_2

Note 1 - Nature of the Business and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Grocery (including Online), Mass and Club $ 71,025,035 $ 54,712,007 $ 200,128,333 $ 150,340,440 Pet Specialty and Natural 13,164,877 10,553,894 34,139,443 29,769,842 Net Sales $ 84,189,912 $ 65,265,901 $ 234,267,776 $ 180,110,282

Note 2 - Inventories (Tables)

Note 2 - Inventories (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, December 31, 2020 2019 Raw Materials and Work in Process $ 6,894,283 $ 4,453,498 Packaging Components Material 1,502,385 1,419,155 Finished Goods 9,589,548 6,842,359 17,986,216 12,715,012 Reserve for Obsolete Inventory (475,377 ) (172,743 ) $ 17,510,839 $ 12,542,269

Note 3 - Property, Plant and _2

Note 3 - Property, Plant and Equipment (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, December 31, 2020 2019 Refrigeration Equipment $ 104,739,451 $ 97,568,137 Machinery and Equipment 70,312,048 54,274,118 Building, Land, and Improvements 27,388,013 25,621,495 Furniture and Office Equipment 5,091,775 4,931,703 Leasehold Improvements 740,385 395,241 Automotive Equipment 159,819 309,137 Construction in Progress 116,949,086 58,587,375 325,380,577 241,687,206 Less: Accumulated Depreciation (83,081,430 ) (76,399,609 ) $ 242,299,147 $ 165,287,597

Note 5 - Accrued Expenses (Tabl

Note 5 - Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	September 30, December 31, 2020 2019 Legal Contingency (1) - 10,100,000 Accrued Compensation and Employee Related Costs 5,302,127 6,390,692 Accrued Chiller Cost 2,129,179 1,576,214 Accrued Customer Consideration 972,344 635,399 Accrued Freight 1,072,878 702,673 Accrued Production Expenses 839,193 413,550 Accrued Marketing 531,966 1,187,885 Other Accrued Expenses 1,110,633 1,126,515 $ 11,958,320 $ 22,132,928

Note 7 - Leases (Tables)

Note 7 - Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Lease, Cost [Table Text Block]	Weighted-average remaining lease term 5.53 Weighted-average discount rate 6.14 % For the Three Months Ended For the Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Operating lease cost $ 446,598 $ 452,155 $ 1,349,055 $ 1,153,370 For the Three Months Ended For the Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Operating cash flow information: Cash paid for amounts included in the measurement of lease liabilities $ 432,786 $ 395,408 $ 1,273,994 $ 1,022,188
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	September 30, 2020 2020 (a) 432,786 2021 1,760,250 2022 1,767,797 2023 1,802,007 2024 1,511,214 2025 and beyond 2,786,004 Total lease payments 10,060,058 Less: Imputed interest (1,358,752 ) Present value of lease liabilities $ 8,701,306

Note 8 - Equity Incentive Pla_2

Note 8 - Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Service Period Stock Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,359,990 $ 11.50 Granted 59,782 65.62 Exercised (361,446 ) 8.86 Forfeited (357 ) 11.00 Outstanding at September 30, 2020 1,057,969 $ 15.46 Performance Based Options Shares Weighted Average Exercise Price Outstanding at December 31, 2019 1,372,819 $ 18.31 Granted 19,317 63.87 Exercised (46,595 ) 31.54 Outstanding at September 30, 2020 1,345,541 $ 18.51
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Restricted Stock Units Shares Weighted-Average Grant-Date Fair Value Per Unit Outstanding at December 31, 2019 240,229 $ 29.07 Granted 55,163 64.58 Issued upon vesting (100,587 ) 30.74 Forfeited (1,102 ) 41.88 Outstanding at September 30, 2020 193,703 $ 38.24

Note 9 - Earnings Per Share A_2

Note 9 - Earnings Per Share Attributable to Common Shareholder (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three months ended Nine Months Ended September 30, September 30, 2020 2019 2020 Net Income (Loss) Attributable to Common Stockholders $ 3,547,033 $ 3,067,163 $ 109,894 Weighted Average Common Shares Outstanding, Basic 40,560,104 36,079,935 39,451,675 Dilutive Effect of Share-Based Awards: Service Period Stock Options 977,604 1,037,873 880,177 Restricted Stock Units 141,020 152,661 121,263 Performance 21,135 19,009 20,175 Weighted Average Common Shares Outstanding, Diluted 41,699,862 37,289,478 40,473,290 Basic Earnings per Share $ 0.09 $ 0.09 $ 0.00 Diluted Earnings per Share $ 0.09 $ 0.08 $ 0.00
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Nine Months Ended September 30, 2019 Service Period Stock Options 1,535,762 Restricted Stock Units 234,091 Performance Stock Options 24,246 Total 1,794,099

Note 1 - Nature of the Busine_3

Note 1 - Nature of the Business and Summary of Significant Accounting Policies (Details Textual) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	0			0	25,967	31,734
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation					$ 1.6	$ 1.3
Amortization of Debt Issuance Costs					0.8
Fees Associated with Debt Modification		$ 0.8
Other Noncurrent Assets [Member]
Debt Issuance Costs, Net, Total	$ 1.1				1.1
Other Current Assets [Member]
Debt Issuance Costs, Net, Total	$ 0.3				$ 0.3
Draw Term Loan [Member]
Amortization of Debt Issuance Costs			$ 0.6
Payments of Debt Restructuring Costs		$ 0.6

Note 1 - Nature of the Busine_4

Note 1 - Nature of the Business and Summary of Significant Accounting Policies - Net Sales by Class of Retailer (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net Sales	$ 84,189,912	$ 65,265,901	$ 234,267,776	$ 180,110,282
Grocery (including Online), Mass and Club [Member]
Net Sales	71,025,035	54,712,007	200,128,333	150,340,440
Pet Specialty and Natural [Member]
Net Sales	$ 13,164,877	$ 10,553,894	$ 34,139,443	$ 29,769,842

Note 2 - Inventories - Summary

Note 2 - Inventories - Summary of Inventories (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Raw Materials and Work in Process	$ 6,894,283	$ 4,453,498
Packaging Components Material	1,502,385	1,419,155
Finished Goods	9,589,548	6,842,359
Inventory, Gross, Total	17,986,216	12,715,012
Reserve for Obsolete Inventory	(475,377)	(172,743)
Inventory, Net, Total	$ 17,510,839	$ 12,542,269

Note 3 - Property, Plant and _3

Note 3 - Property, Plant and Equipment (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Depreciation, Total	$ 4,970,451	$ 3,975,822	$ 14,708,962	$ 11,462,514
Selling, General and Administrative Expenses [Member]
Depreciation, Total	$ 2,128,590	$ 1,598,843	$ 6,422,288	$ 4,753,623

Note 3 - Property, Plant and _4

Note 3 - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Property, plant and equipment, gross	$ 325,380,577	$ 241,687,206
Less: Accumulated Depreciation	(83,081,430)	(76,399,609)
Property, Plant and Equipment, Net, Ending Balance	242,299,147	165,287,597
Refrigeration Equipment [Member]
Property, plant and equipment, gross	104,739,451	97,568,137
Machinery and Equipment [Member]
Property, plant and equipment, gross	70,312,048	54,274,118
Land, Buildings and Improvements [Member]
Property, plant and equipment, gross	27,388,013	25,621,495
Furniture and Office Equipment [Member]
Property, plant and equipment, gross	5,091,775	4,931,703
Leasehold Improvements [Member]
Property, plant and equipment, gross	740,385	395,241
Automotive Equipment [Member]
Property, plant and equipment, gross	159,819	309,137
Construction in Progress [Member]
Property, plant and equipment, gross	$ 116,949,086	$ 58,587,375

Note 4 - Equity Method Invest_2

Note 4 - Equity Method Investment (Details Textual) - USD ($)	Sep. 02, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Payments to Acquire Equity Method Investments		$ 27,624,501	$ 0
Equity Method Investments		27,749,501		$ 0
Income (Loss) from Equity Method Investments, Total		$ 0
Privately Held Company [Member]
Equity Method Investment, Ownership Percentage	19.00%
Payments to Acquire Equity Method Investments	$ 27,700,000
Equity Method Investments	26,600,000
Equity Method Investment, Aggregate Cost	$ 1,100,000

Note 5 - Accrued Expenses - Sum

Note 5 - Accrued Expenses - Summary of Accrued Expenses (Details) - USD ($)		Sep. 30, 2020	Dec. 31, 2019
Legal Contingency (1)	[1]	$ 0	$ 10,100,000
Accrued Compensation and Employee Related Costs		5,302,127	6,390,692
Accrued Chiller Cost		2,129,179	1,576,214
Accrued Customer Consideration		972,344	635,399
Accrued Freight		1,072,878	702,673
Accrued Production Expenses		839,193	413,550
Accrued Marketing		531,966	1,187,885
Other Accrued Expenses		1,110,633	1,126,515
Accrued Liabilities, Current, Total	[1]	$ 11,958,320	$ 22,132,928
[1]	See Note 11 for additional information.

Note 6 - Debt (Details Textual)

Note 6 - Debt (Details Textual) - USD ($)	Apr. 17, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	May 15, 2019
Proceeds from Lines of Credit, Total		$ 20,933,000	$ 50,620,988
Repayments of Lines of Credit		76,000,000	$ 15,900,000
Amortization of Debt Issuance Costs		800,000
Unamortized Debt Issuance Expense		1,300,000
Credit Facility [Member]
Debt Agreement, Maximum Borrowing Capacity	$ 165,000,000
Long-term Debt, Total		0
Proceeds from Debt Agreement		20,900,000		$ 54,500,000
Repayments of Lines of Credit		76,000,000
Credit Facility [Member] | Base Rate [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Facility [Member] | Base Rate [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate	1.00%
Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate	1.50%
Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate	2.00%
Credit Facility [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 35,000,000				$ 35,000,000
Proceeds from Lines of Credit, Total		7,000,000		14,000,000
Credit Facility [Member] | Draw Term Loan [Member]
Long-term Debt, Total	$ 130,000,000				$ 55,000,000
Proceeds from Issuance of Long-term Debt, Total		13,900,000		40,500,000
Debt Issuance Costs, Net, Total		$ 100,000		$ 600,000

Note 7 - Leases (Details Textua

Note 7 - Leases (Details Textual)	Sep. 30, 2020
Lessee, Operating Lease, Renewal Term (Year)	5 years
Minimum [Member]
Lessee, Operating Lease, Remaining Lease Term (Year)	2 years
Maximum [Member]
Lessee, Operating Lease, Remaining Lease Term (Year)	9 years

Note 7 - Leases - Lease Cost (D

Note 7 - Leases - Lease Cost (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Weighted-average remaining lease term (Year)	5 years 6 months 10 days		5 years 6 months 10 days
Weighted-average discount rate	6.14%		6.14%
Operating lease cost	$ 446,598	$ 452,155	$ 1,349,055	$ 1,153,370
Cash paid for amounts included in the measurement of lease liabilities	$ 432,786	$ 395,408	$ 1,273,994	$ 1,022,188

Note 7 - Leases - Maturities of

Note 7 - Leases - Maturities of Lease Liabilities (Details)	Sep. 30, 2020USD ($)
2020 (a)	$ 432,786	[1]
2021	1,760,250
2022	1,767,797
2023	1,802,007
2024	1,511,214
2025 and beyond	2,786,004
Total lease payments	10,060,058
Less: Imputed interest	(1,358,752)
Present value of lease liabilities	$ 8,701,306
[1]	Excluding the nine months ended September 30, 2020.

Note 8 - Equity Incentive Pla_3

Note 8 - Equity Incentive Plans (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount, Total		$ 3,409,728	$ 3,129,648	$ 7,984,490	$ 5,870,657
NASDAQ Marketplace Rules Inducement Award [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)				4 years
NASDAQ Marketplace Rules Inducement Award [Member] | Executive Vice President of Finance [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)				3 years
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in shares)	1,285,774	1,285,774		1,285,774
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 18.66	$ 18.66		$ 18.66
Stock Plan 2010 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)	0	0		0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)	53,028	53,028		53,028
Stock Plan 2010 [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)				2 years
Stock Plan 2010 [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)				4 years
Omnibus Incentive Plan 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)	2,548,891	2,548,891		2,548,891
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares)	700,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)	4,679,200	4,679,200		4,679,200
Common Stock, Capital Shares Reserved for Future Issuance (in shares)	1,344,050	1,344,050		1,344,050
Omnibus Incentive Plan 2014 [Member] | Restricted Stock Units (RSUs) [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	3 years
Omnibus Incentive Plan 2014 [Member] | Restricted Stock Units (RSUs) [Member] | Non-employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	1 year

Note 8 - Equity Incentive Pla_4

Note 8 - Equity Incentive Plans - Options Activity (Details)	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Service Period Stock Options [Member]
Outstanding at December 31, 2019 (in shares) | shares	1,359,990
Outstanding at December 31, 2019, weighted average exercise price (in dollars per share) | $ / shares	$ 11.50
Granted (in shares) | shares	59,782
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 65.62
Exercised (in shares) | shares	(361,446)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 8.86
Forfeited (in shares) | shares	(357)
Forfeited, weighted average exercise price (in dollars per share) | $ / shares	$ 11
Outstanding at September 30, 2020 (in shares) | shares	1,057,969
Outstanding at June 30, 2020, weighted average exercise price (in dollars per share) | $ / shares	$ 15.46
Performance Shares [Member]
Outstanding at December 31, 2019 (in shares) | shares	1,372,819
Outstanding at December 31, 2019, weighted average exercise price (in dollars per share) | $ / shares	$ 18.31
Granted (in shares) | shares	19,317
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 63.87
Exercised (in shares) | shares	(46,595)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 31.54
Outstanding at September 30, 2020 (in shares) | shares	1,345,541
Outstanding at June 30, 2020, weighted average exercise price (in dollars per share) | $ / shares	$ 18.51

Note 8 - Equity Incentive Pla_5

Note 8 - Equity Incentive Plans - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Outstanding at December 31, 2019 (in shares) | shares	240,229
Outstanding at December 31, 2019, weighted average grant date fair value (in dollars per share) | $ / shares	$ 29.07
Granted (in shares) | shares	55,163
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 64.58
Issued upon vesting (in shares) | shares	(100,587)
Issued upon vesting, weighted average grant date fair value (in dollars per share) | $ / shares	$ 30.74
Forfeited (in shares) | shares	(1,102)
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	$ 41.88
Outstanding at September 30, 2020 (in shares) | shares	193,703
Outstanding at June 30, 2020, weighted average grant date fair value (in dollars per share) | $ / shares	$ 38.24

Note 9 - Earnings Per Share A_3

Note 9 - Earnings Per Share Attributable to Common Shareholder - Schedule of Earnings Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net Income (Loss) Attributable to Common Stockholders	$ 3,547,033	$ 3,067,163	$ 109,894
Weighted Average Common Shares Outstanding, Basic (in shares)	40,560,104	36,079,935	39,451,675	35,894,377
Weighted Average Common Shares Outstanding, Diluted (in shares)	41,699,862	37,289,478	40,473,290	35,894,377
Basic Earnings per Share (in dollars per share)	$ 0.09	$ 0.09	$ 0	$ (0.17)
Diluted Earnings per Share (in dollars per share)	$ 0.09	$ 0.08	$ 0	$ (0.17)
Service Period Stock Options [Member]
Effect of Share-Based Awards (in shares)	977,604	1,037,873	880,177
Restricted Stock Units (RSUs) [Member]
Effect of Share-Based Awards (in shares)	141,020	152,661	121,263
Performance Shares [Member]
Effect of Share-Based Awards (in shares)	21,135	19,009	20,175

Note 9 - Earnings Per Share A_4

Note 9 - Earnings Per Share Attributable to Common Shareholder - Potentially Dilutive Securities (Details)	9 Months Ended
	Sep. 30, 2019shares
Potentially dilutive securities (in shares)	1,794,099
Service Period Stock Options [Member]
Potentially dilutive securities (in shares)	1,535,762
Restricted Stock Units (RSUs) [Member]
Potentially dilutive securities (in shares)	234,091
Performance Shares [Member]
Potentially dilutive securities (in shares)	24,246

Note 10 - Concentrations (Detai

Note 10 - Concentrations (Details Textual)	Sep. 30, 2020USD ($)
Cash, FDIC Insured Amount	$ 250,000

Note 11 - Commitments and Con_2

Note 11 - Commitments and Contingencies (Details Textual) - USD ($)		Sep. 30, 2020	Dec. 31, 2019
Accrued Legal Contingencies, Current	[1]	$ 0	$ 10,100,000
Meldon v. Freshpet, Inc. [Member]
Accrued Legal Contingencies, Current		$ 200,000
[1]	See Note 11 for additional information.